Photoreceptor degeneration is the hallmark of a group of inherited blinding diseases collectively termed retinitis pigmentosa (RP); a major cause of blindness in humans. RP is at present untreatable and the underlying neurodegenerative mechanisms are largely unknown, even though the genetic causes are often established. The activation of calpain-type proteases may play an important role in cell death in various neuronal tissues, including the retina. We therefore tested the efficacy of two different calpain inhibitors in preventing cell death in the retinal degeneration (rd1) human homologous mouse model for RP. Pharmacological inhibition of calpain activity in rd1 organotypic retinal explants had ambiguous effects on photoreceptor viability. Calpain inhibitor XI had protective effects when applied for short periods of time (16 h) but demonstrated substantial levels of toxicity in both wild-type and rd1 retina when used over several days. In contrast, the highly specific calpain inhibitor calpastatin peptide reduced photoreceptor cell death in vitro after both short and prolonged exposure, an effect that was also evident after in vivo application via intravitreal injection. These findings highlight the importance of calpain activation for photoreceptor cell death but also for photoreceptor survival and propose the use of highly specific calpain inhibitors to prevent or delay RP.
|Data di pubblicazione:||2010|
|Titolo:||Photoreceptor rescue and toxicity induced by different calpain inhibitors.|
|Autori:||F., Paquet Durand; D. Sanges, D.; J., Mccall; J., Silva; T., van Veen; Marigo, Valeria; P., Ekström|
|Digital Object Identifier (DOI):||10.1111/j.1471-4159.2010.06983.x|
|Appare nelle tipologie:||Articolo su rivista|
File in questo prodotto:
|Paquet-Durand et al 2010 - Photoreceptor rescue and toxicity induced by different calpain inhibitors - rev1a.pdf||Post-print||Open Access Visualizza/Apri|
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris